Atlas Trials

Study on Patients With Rasmussen Encephalitis Treated With Adalimumab: Efficacy and Tolerance in the Short and Long Term

Clinical trial NCT04003922 · UNKNOWN

Trial details

NCT number
NCT04003922
Sponsor
Assistance Publique Hopitaux De Marseille
Status
UNKNOWN
Study type
OBSERVATIONAL
Rasmussen Encephalitis
Start date
2020-04-21
Primary completion
2024-04-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.